OTC · Drug Manufacturers - Specialty & Generic

Next Science Limited (NXSCF) Stock

$0.00 OTC: NXSCF Healthcare

Next Science Limited operates as a medical technology firm, dedicated to the research, development, and commercialization of innovative solutions aimed at mitigating the detrimental effects of biofilms on human health. The company serves markets in both the United States and Australia, building its product portfolio on its proprietary Xbio Technology platform.

Valuation

MetricValue
Price$0.00
Market Cap$292625
P/E Ratio-0.03
P/B Ratio0.10
P/S Ratio0.01
EPS (TTM)$-0.04
52-Week High$0.11
52-Week Low$0.00
Dividend Yield—

Financials & Margins

MetricValue
ROE-366.67%
ROA-122.22%
ROCE-171.87%
Gross Margin-43.48%
Operating Margin-43.48%
Net Margin-47.83%
Debt/Equity0.67
Current Ratio2.00

Annual Financials (USD)

Metric20202021202220232024
Revenue$3.0M$9.0M$12.0M$22.0M$23.0M
Operating Profit$-14.0M$-9.0M$-13.0M$-16.0M$-10.0M
Net Profit$-13.0M$-9.0M$-18.0M$-25.0M$-11.0M
EPS$-0.07$-0.05$-0.09$-0.07$-0.04
Op Margin-408.2%-103.7%-108.5%-71.9%-45.2%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$23.0M$14.0M$18.0M$18.0M$9.0M
Total Liabilities$5.0M$3.0M$7.0M$5.0M$6.0M
Cash$8.0M$7.0M$7.0M$9.0M$2.0M
Borrowings$0$0$1.0M$1.0M$2.0M

Latest News

ON Semiconductor's AI Momentum Outpaces Financial Results, Truist Says MT Newswires · Aug 4, 2026 Waters Corp (WAT) (Q2 2026) Earnings Call Highlights: Strong Organic Growth and Raised Guidance ... GuruFocus.com · Aug 4, 2026 FSN E-Commerce Ventures Ltd (BOM:543384) (Q1 2027) Earnings Call Highlights: GMV Surges 34% and ... GuruFocus.com · Aug 4, 2026 Revvity Inc (RVTY) (Q2 2026) Earnings Call Highlights: Strong Diagnostics Growth and Raised ... GuruFocus.com · Aug 4, 2026 Cabot Corp (CBT) (Q3 2026) Earnings Call Highlights: Strong Performance Chemicals Growth and ... GuruFocus.com · Aug 4, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-13.0M$-8.0M$-17.0M$-15.0M$-8.0M
Investing Cash Flow$-2.0M$-1.0M$-1.0M$-2.0M$-1.0M
Financing Cash Flow$-4.0M$0$-5.0M$-8.0M$0
Net Cash Flow$-9.0M$-8.0M$-2.0M$4.0M$-8.0M
Free Cash Flow$-14.0M$-9.0M$-18.0M$-16.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.12
FCF Yield-2922.72%
Quick Ratio1.65
Interest Coverage-36.29
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AHGIFAlternate Health Corp. $0.00 — 0.00 $7788 0.00%
CNTMFFluent Corp. $0.02 +8.33% -0.17 $10.35M 0.00%
CWBHFCharlotte's Web Holdings, Inc. $0.25 +4.12% -1.08 $39.86M 0.00%
ELXMFNova Eye Medical Limited $0.01 +0.00% -4.69 $4.08M 0.00%
EOFBFEcofibre Ltd. $0.00 — -0.17 $378874 0.00%

About Next Science Limited

Next Science Limited operates as a medical technology firm, dedicated to the research, development, and commercialization of innovative solutions aimed at mitigating the detrimental effects of biofilms on human health. The company serves markets in both the United States and Australia, building its product portfolio on its proprietary Xbio Technology platform. Among its key offerings are: SURGX: An antimicrobial gel employed for managing surgical infections. BACTISURE: A specialized wound lavage designed to eliminate biofilm. BlastX: An antimicrobial wound gel that not only eradicates bacteria within the gel but also wards off recolonization, all while maintaining an optimal moist healing environment. XPERIENCE: A no-rinse antimicrobial solution developed specifically to deter surgical site infections. Established in 2012, Next Science Limited maintains its primary operational base in Chatswood, Australia.

Next Science Limited (NXSCF) stock trades at $0.00 with a market capitalization of $292625. The stock is valued at a price-to-earnings (P/E) ratio of -0.03, price-to-book of 0.10, price-to-sales of 0.01. Over the past 52 weeks the stock has ranged between $0.00 and $0.11, and currently trades 100.0% below its 52-week high.

On profitability, Next Science Limited generates a return on equity (ROE) of -366.67%, return on capital employed of -171.87%, an operating margin of -43.48%, a net profit margin of -47.83%.

Official website: www.nextscience.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides